Clinical Usefulness of Combined Cardiac Marker Testing with a Point-of-Care Device at the Emergency Department.
10.15263/jlmqa.2017.39.2.83
- Author:
Misuk JI
1
;
Hee Won MOON
;
Seungman PARK
;
Mina HUR
;
Yeo Min YUN
Author Information
1. Department of Laboratory Medicine, Veterans Health Service Medical Center, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Troponin I;
B-type natriuretic peptide;
Emergency department
- MeSH:
Acute Coronary Syndrome;
Electronic Health Records;
Emergencies*;
Emergency Service, Hospital*;
Heart Failure;
Humans;
Length of Stay;
Natriuretic Peptide, Brain;
Point-of-Care Systems*;
Triage;
Troponin;
Troponin I
- From:Journal of Laboratory Medicine and Quality Assurance
2017;39(2):83-89
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: B-type natriuretic peptide (BNP) levels are elevated in various conditions unrelated to heart failure, such as acute coronary syndrome, and cardiac troponin (cTn) levels may also be elevated in several non-ischemic conditions. This study aimed to evaluate the clinical usefulness of combined cardiac marker testing (BNP and cTnI) with point-of-care devices in patients who presented to the emergency department (ED). METHODS: Two thousand six hundred and seventy-four consecutive patients who visited the ED from March to August 2013 were included in this study. Cardiac marker testing was performed using the Triage Cardio3 panel (Alere, USA). Electronic medical records were collected on August 2014. RESULTS: We found that 22.2% patients had elevated BNP and/or cTnI (12.8% with only elevated BNP, 4.4% with only elevated cTnI, and 5.0% with both elevations). Patients with elevations in both marker levels showed significantly higher admission rate (78.5% vs. 62.7%, P=0.006) and longer length of hospital stay (11 vs. 6 days, P=0.001) than those with only elevated cTnI. Patients with elevations in both marker levels also showed higher admission rate (78.5% vs. 67.3%, P=0.016) and higher BNP levels (430 vs. 194 pg/mL, P<0.001) than those with only elevated BNP. CONCLUSIONS: Concurrent elevation of BNP and cTnI may be associated with inferior clinical outcome and combined testing of cTnI and BNP levels with high sensitivity would provide important information for assisting management decisions at the ED.
